These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27246230)

  • 1. Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study.
    García-Martínez L; Gracia-Ahulfinger I; Machuca I; Cantisán S; De La Fuente S; Natera C; Pérez-Nadales E; Vidal E; Rivero A; Rodríguez-Lopez F; Del Prado JR; Torre-Cisneros J
    J Antimicrob Chemother; 2016 Sep; 71(9):2606-11. PubMed ID: 27246230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid Consumption Facilitates the Development of Linezolid Resistance in
    Bai B; Hu K; Zeng J; Yao W; Li D; Pu Z; Chen Z; Cheng H; Zheng J; Pan W; Lin Z; Xie L; Deng Q; Yu Z
    Microb Drug Resist; 2019; 25(6):791-798. PubMed ID: 30762463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms.
    Ramírez E; Gómez-Gil R; Borobia AM; Moreno F; Zegarra C; Muñoz R; Reutero Z; de Montreuil C; González D; Hernández S; Herrero A; Gutiérrez A; Frías J
    Int J Antimicrob Agents; 2013 Feb; 41(2):174-8. PubMed ID: 23276501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
    Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
    J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of mechanisms and molecular epidemiology of linezolid nonsusceptible Enterococcus faecalis isolated from a teaching hospital in China.
    Li B; Ma CL; Yu X; Sun Y; Li MM; Ye JZ; Zhang YP; Wu Q; Zhou TL
    J Microbiol Immunol Infect; 2016 Aug; 49(4):595-9. PubMed ID: 26210761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empyema thoracis caused by an optrA-positive and linezolid-intermediate Enterococcus faecalis strain.
    Chien JY; Mendes RE; Deshpande LM; Hsueh PR
    J Infect; 2017 Aug; 75(2):182-184. PubMed ID: 28506787
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.
    Wang L; He Y; Xia Y; Wang H; Liang S
    Infect Genet Evol; 2014 Aug; 26():14-9. PubMed ID: 24815727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Linezolid-resistant Enterococcus in a Children's Hospital.
    Bagga B; Buckingham S; Arnold S; Nesbitt A; Guimera D; Lee K
    Pediatr Infect Dis J; 2018 Mar; 37(3):242-244. PubMed ID: 29189675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which antibiotic for resistant Gram-positives, and why?
    Bradley JS
    J Infect; 2014 Jan; 68 Suppl 1():S63-75. PubMed ID: 24188585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid: a promising option in the treatment of Gram-positives.
    Zahedi Bialvaei A; Rahbar M; Yousefi M; Asgharzadeh M; Samadi Kafil H
    J Antimicrob Chemother; 2017 Feb; 72(2):354-364. PubMed ID: 27999068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
    Gómez-Gil R; Romero-Gómez MP; García-Arias A; Ubeda MG; Busselo MS; Cisterna R; Gutiérrez-Altés A; Mingorance J
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):175-9. PubMed ID: 19717261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
    Papadimitriou-Olivgeris M; Kolonitsiou F; Zerva L; Lebessi E; Koutsia C; Drougka E; Sarrou S; Giormezis N; Vourli S; Doudoulakakis A; Konsolakis C; Marangos M; Anastassiou ED; Petinaki E; Spiliopoulou I
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):386-8. PubMed ID: 26341703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
    Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
    BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
    Tu EY; Jain S
    Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
    Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
    Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
    Lopez Marti MG; Jhaveri R
    Pediatr Infect Dis J; 2009 Jul; 28(7):663-4. PubMed ID: 19451857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
    Flamm RK; Mendes RE; Hogan PA; Ross JE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):283-9. PubMed ID: 25633420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit.
    Balandin B; Lobo B; Orden B; Román F; García E; Martínez R; Valdivia M; Ortega A; Fernández I; Galdos P
    Infect Dis (Lond); 2016; 48(5):343-9. PubMed ID: 26670684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and impact of an audit and feedback antimicrobial stewardship intervention in the orthopaedics department of a tertiary-care hospital: a controlled interrupted time series study.
    Tavares M; Carvalho AC; Almeida JP; Andrade P; São-Simão R; Soares P; Alves C; Pinto R; Fontanet A; Watier L
    Int J Antimicrob Agents; 2018 Jun; 51(6):925-931. PubMed ID: 29339298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.